RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
-17.9%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$4.58B
AUM Growth
+$4.58B
Cap. Flow
+$268M
Cap. Flow %
5.84%
Top 10 Hldgs %
44.83%
Holding
107
New
10
Increased
11
Reduced
7
Closed
11

Top Buys

1
BIIB icon
Biogen
BIIB
$153M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
$68.6M
3
ANTX icon
AN2 Therapeutics
ANTX
$55.3M
4
NTRA icon
Natera
NTRA
$53.3M
5
VERA icon
Vera Therapeutics
VERA
$46.2M

Top Sells

1
NVAX icon
Novavax
NVAX
$103M
2
PHAT icon
Phathom Pharmaceuticals
PHAT
$61.3M
3
ZGNX
Zogenix, Inc.
ZGNX
$54.2M
4
CCCC icon
C4 Therapeutics
CCCC
$44.4M
5
TGTX icon
TG Therapeutics
TGTX
$42M

Sector Composition

1 Healthcare 97.97%
2 Financials 0.96%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EWTX icon
51
Edgewise Therapeutics
EWTX
$1.51B
$25.4M 0.55%
2,613,623
– –
STSA
52
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$22.5M 0.49%
5,914,252
– –
CNTB
53
Connect Biopharma
CNTB
$115M
$21.1M 0.46%
6,991,003
– –
HOWL icon
54
Werewolf Therapeutics
HOWL
$59.9M
$18.9M 0.41%
4,291,881
– –
ETNB icon
55
89bio
ETNB
$1.34B
$18.7M 0.41%
4,965,769
– –
TNGX icon
56
Tango Therapeutics
TNGX
$747M
$17.1M 0.37%
2,250,000
– –
RLAY icon
57
Relay Therapeutics
RLAY
$619M
$16.4M 0.36%
549,055
– –
KDNY
58
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$16.4M 0.36%
1,000,000
– –
SYBX icon
59
Synlogic
SYBX
$17M
$16M 0.35%
6,666,666
– –
WVE icon
60
Wave Life Sciences
WVE
$1.53B
$15.6M 0.34%
7,775,207
– –
SCPH icon
61
scPharmaceuticals
SCPH
$295M
$15.1M 0.33%
2,658,583
-33,187
-1% -$189K
KALA icon
62
KALA BIO
KALA
$78.8M
$15M 0.33%
10,874,613
– –
SLDB icon
63
Solid Biosciences
SLDB
$427M
$14.8M 0.32%
12,367,873
– –
ACHL
64
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$14.7M 0.32%
5,014,687
– –
DALS
65
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$14.6M 0.32%
1,500,000
– –
MIST icon
66
Milestone Pharmaceuticals
MIST
$156M
$14.4M 0.31%
2,246,503
– –
XLO icon
67
Xilio Therapeutics
XLO
$36.3M
$14.2M 0.31%
2,002,217
– –
LENZ
68
LENZ Therapeutics
LENZ
$1.1B
$13.8M 0.3%
2,698,369
– –
OTIC
69
DELISTED
Otonomy, Inc.
OTIC
$13.4M 0.29%
5,600,000
– –
CYT
70
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$12.6M 0.28%
3,350,506
– –
BLSA
71
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$12.3M 0.27%
1,250,000
– –
IPSC icon
72
Century Therapeutics
IPSC
$42.5M
$11.5M 0.25%
914,094
– –
MORF
73
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$11.2M 0.24%
+278,874
New +$11.2M
AKUS
74
DELISTED
Akouos, Inc. Common Stock
AKUS
$10.8M 0.24%
2,281,249
– –
CNCE
75
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$10.2M 0.22%
3,033,603
– –
1 2
3
4 5